# FDA Inspection 1191641 - Celquest LLC - November 21, 2022

Source: https://www.keypedia.com/records/fda_inspections/celquest-llc/717c598f-3f45-4a1d-8d02-b8cf28f2d4c4
Source feed: FDA_Inspections

> FDA Inspection 1191641 for Celquest LLC on November 21, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191641
- Company Name: Celquest LLC
- Inspection Date: 2022-11-21
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1191641 - 2022-11-21](https://www.keypedia.com/records/fda_inspections/celquest-llc/6062a5b3-6aee-425f-8d6a-49513e7a292e)
- [FDA Inspection 1191641 - 2022-11-21](https://www.keypedia.com/records/fda_inspections/celquest-llc/14ad580a-c922-41d8-b86e-5825db639a2b)

Company: https://www.keypedia.com/companies/celquest-llc/c763478f-10fe-4553-b17f-20d859b0ca30

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d